| Trial ID: | L1818 |
| Source ID: | NCT00513630
|
| Associated Drug: |
Glipizide
|
| Title: |
Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
|
| Acronym: |
SPREADDIMCAD
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Coronary Artery Disease
|
| Interventions: |
DRUG: Glipizide|DRUG: Metformin
|
| Outcome Measures: |
Primary: Composite of cardiovascular events which were defined as death from a cardiovascular cause, death from any cause, nonfatal myocardial infarction, nonfatal stroke or arterial revascularization | Secondary: New or worsening angina|new or worsening heart failure|new critical cardiac arrhythmia|new peripheral vascular events
|
| Sponsor/Collaborators: |
Sponsor: Shanghai Jiao Tong University School of Medicine
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
304
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-06
|
| Completion Date: |
2010-07
|
| Results First Posted: |
|
| Last Update Posted: |
2011-04-26
|
| Locations: |
Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00513630
|
